Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. Now the FDA has ...

To better understand which social media platforms Americans use, Pew Research Center surveyed 5,022 U.S. adults from Feb. 5 to June 18, 2025. SSRS conducted this National Public Opinion Reference ...

ResMed is rated a buy due to strong fundamentals, expanding margins, robust cash flow, and resilience in recessionary environments. RMD's steady topline growth, high profitability, low debt, and ...

What is it with lawyers and AI? We don’t know, but it feels like an inordinate number of them keep screwing up with AI tools, apparently never learning from their colleagues who get publicly crucified ...

Fractus, a company specializing in geometry-based antenna technology and IP licensing, has filed a patent infringement suit against respiratory leader ResMed. The complaint was filed in the United ...

A large number of Americans are using PTO to sleep rather than take a vacation, according to a new report. An Amerisleep.com survey of more than 1,200 Americans revealed that 37 percent used vacation ...

Researchers investigated the bathroom habits of 125 adults. People who use their smartphones while sitting on the toilet face are at higher risk for painful, itchy hemorrhoids, according to new ...

Kara Alaimo is an associate professor of communication at Fairleigh Dickinson University. Her book “Over the Influence: Why Social Media Is Toxic for Women and Girls — And How We Can Take It Back” was ...

Robin Brewer receives funding from the National Science Foundation and the National Institutes of Health. She has previously received funding from Google, the Retirement Research Foundation, and the U ...

ResMed Inc. (NYSE:RMD) Q4 2025 Earnings Call Transcript July 31, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.55, expectations were $2.49. Operator: Hello, and welcome to the Q4 ...

Resmed Inc (NYSE:RMD) reported better-than-expected earnings for the second quarter on Thursday. The company posted quarterly earnings of $2.55 per share which beat the analyst consensus estimate of ...

July 31 (Reuters) - Resmed (RMD.N), opens new tab beat Wall Street estimates for fourth-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea. The company ...